1. Home
  2. CRGX vs USNA Comparison

CRGX vs USNA Comparison

Compare CRGX & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • USNA
  • Stock Information
  • Founded
  • CRGX 2021
  • USNA 1992
  • Country
  • CRGX United States
  • USNA United States
  • Employees
  • CRGX N/A
  • USNA N/A
  • Industry
  • CRGX
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • CRGX
  • USNA Health Care
  • Exchange
  • CRGX Nasdaq
  • USNA Nasdaq
  • Market Cap
  • CRGX 621.4M
  • USNA 636.2M
  • IPO Year
  • CRGX 2023
  • USNA 1996
  • Fundamental
  • Price
  • CRGX $12.39
  • USNA $33.99
  • Analyst Decision
  • CRGX Strong Buy
  • USNA Hold
  • Analyst Count
  • CRGX 6
  • USNA 1
  • Target Price
  • CRGX $31.80
  • USNA $38.00
  • AVG Volume (30 Days)
  • CRGX 287.3K
  • USNA 130.8K
  • Earning Date
  • CRGX 11-12-2024
  • USNA 02-04-2025
  • Dividend Yield
  • CRGX N/A
  • USNA N/A
  • EPS Growth
  • CRGX N/A
  • USNA N/A
  • EPS
  • CRGX N/A
  • USNA 2.83
  • Revenue
  • CRGX N/A
  • USNA $861,973,000.00
  • Revenue This Year
  • CRGX N/A
  • USNA N/A
  • Revenue Next Year
  • CRGX N/A
  • USNA $11.73
  • P/E Ratio
  • CRGX N/A
  • USNA $12.02
  • Revenue Growth
  • CRGX N/A
  • USNA N/A
  • 52 Week Low
  • CRGX $10.91
  • USNA $31.44
  • 52 Week High
  • CRGX $33.92
  • USNA $52.75
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 39.66
  • USNA 40.18
  • Support Level
  • CRGX $10.91
  • USNA $33.34
  • Resistance Level
  • CRGX $15.75
  • USNA $36.99
  • Average True Range (ATR)
  • CRGX 1.20
  • USNA 0.96
  • MACD
  • CRGX -0.11
  • USNA -0.05
  • Stochastic Oscillator
  • CRGX 30.08
  • USNA 22.68

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Share on Social Networks: